JP2009521932A - 抗菌性カテリシジンペプチド - Google Patents

抗菌性カテリシジンペプチド Download PDF

Info

Publication number
JP2009521932A
JP2009521932A JP2008548779A JP2008548779A JP2009521932A JP 2009521932 A JP2009521932 A JP 2009521932A JP 2008548779 A JP2008548779 A JP 2008548779A JP 2008548779 A JP2008548779 A JP 2008548779A JP 2009521932 A JP2009521932 A JP 2009521932A
Authority
JP
Japan
Prior art keywords
polypeptide
seq
nucleic acid
variant
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008548779A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009521932A5 (cg-RX-API-DMAC7.html
Inventor
トナティウー メルガレホ，
フランク ブレチャ，
ヨンミン サン，
マリア テレサ オルテガ，
Original Assignee
カンザス ステート ユニバーシティー リサーチ ファウンデーション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by カンザス ステート ユニバーシティー リサーチ ファウンデーション filed Critical カンザス ステート ユニバーシティー リサーチ ファウンデーション
Publication of JP2009521932A publication Critical patent/JP2009521932A/ja
Publication of JP2009521932A5 publication Critical patent/JP2009521932A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP2008548779A 2005-12-29 2006-12-29 抗菌性カテリシジンペプチド Pending JP2009521932A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75487805P 2005-12-29 2005-12-29
PCT/US2006/049637 WO2007076162A2 (en) 2005-12-29 2006-12-29 Antimicrobial cathelicidin peptides

Publications (2)

Publication Number Publication Date
JP2009521932A true JP2009521932A (ja) 2009-06-11
JP2009521932A5 JP2009521932A5 (cg-RX-API-DMAC7.html) 2010-02-18

Family

ID=38218737

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008548779A Pending JP2009521932A (ja) 2005-12-29 2006-12-29 抗菌性カテリシジンペプチド

Country Status (8)

Country Link
US (1) US7985832B2 (cg-RX-API-DMAC7.html)
EP (1) EP1966235A4 (cg-RX-API-DMAC7.html)
JP (1) JP2009521932A (cg-RX-API-DMAC7.html)
CN (1) CN101351474A (cg-RX-API-DMAC7.html)
AU (1) AU2006330769A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0621148A2 (cg-RX-API-DMAC7.html)
CA (1) CA2632782A1 (cg-RX-API-DMAC7.html)
WO (1) WO2007076162A2 (cg-RX-API-DMAC7.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006330769A1 (en) * 2005-12-29 2007-07-05 Kansas State University Research Foundation Antimicrobial cathelicidin peptides
JP2009535027A (ja) * 2006-04-27 2009-10-01 シンガポール ヘルス サービシーズ ピーティーイー リミテッド 抗菌ペプチド
US8710272B2 (en) 2007-01-08 2014-04-29 Androscience Corporation Compounds with (1 E, 6E)-1,7-bis-(3,4-dimethoxyphenyl)-4,4-disubstituted-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, and uses thereof
US9000222B2 (en) 2007-01-08 2015-04-07 Androscience Corporation Compounds with (1E, 6E)-1,7-bis-(3,4-dimethoxyphenyl)-4,4-disubstituted-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, and uses thereof
AU2008205312B2 (en) 2007-01-08 2013-11-21 Annji Pharmaceutical Co., Ltd. Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and uses thereof
MX2010001125A (es) 2007-07-31 2010-09-30 Androscience Corp Composiciones incluyendo receptor androgeno de degradacion (ard) ponteciadores y metodos de tratamiento profilactico o terapeutico de trastornos de la piel y la caida de cabello.
AU2008310076A1 (en) * 2007-09-11 2009-04-16 Mondobiotech Laboratories Ag CGRP as a therapeutic agent
KR20100061481A (ko) * 2007-09-11 2010-06-07 몬도바이오테크 래보래토리즈 아게 치료제로서의 미니가스트린
CA2776883A1 (en) * 2009-06-16 2010-12-23 George Mason Intellectual Properties, Inc. Antimicrobial and antibiofilm activity of cathelicidins
AU2010306940A1 (en) 2009-10-12 2012-06-07 Smith, Larry Methods and compositions for modulating gene expression using oligonucleotide based drugs administered in vivo or in vitro
US10174081B2 (en) * 2011-04-21 2019-01-08 George Mason Research Foundation, Inc. Antimicrobial peptides and uses therefore
CN104010653B (zh) 2011-10-31 2019-01-01 凯恩生物科技有限公司 用于预防并治疗口腔疾病的组合物和方法
WO2015196299A1 (en) * 2014-06-27 2015-12-30 Kane Biotech Inc. Antimicrobial-antibiofilm compositions and methods of use thereof for personal care products
US11723852B2 (en) 2011-10-31 2023-08-15 Kane Biotech Inc. Antimicrobial-antibiofilm compositions and methods of use thereof for personal care products
US10357470B2 (en) 2013-03-07 2019-07-23 Kane Biotech Inc. Antimicrobial-antibiofilm compositions and methods of use thereof
US10046137B2 (en) 2014-02-21 2018-08-14 Avadim Technologies, Inc. Method for maintenance of urethral catheters
ES2789351T3 (es) 2015-01-13 2020-10-26 Hope City Máscaras de enlace peptídico de proteínas de unión a CTLA4
CN104830891B (zh) * 2015-03-23 2017-10-31 广东药科大学 一种金环蛇抗菌肽Cath‑BF30的高效制备方法
US20190352377A1 (en) * 2016-11-15 2019-11-21 The Rockefeller University Chimeric antibodies comprising binding domains of phage lysins, bacterial autolysins, bacteriocins, and phage tail or tail fibers
CN109996554B (zh) * 2016-11-21 2024-03-29 匹兹堡大学联邦高等教育系统 新型抗微生物和抗癌疗法
CN109266655B (zh) * 2018-09-06 2021-11-09 浙江大学 一种抗菌肽及其原核表达方法和应用
CA3143518A1 (en) * 2019-06-12 2020-12-17 Avadim Health Ip, Inc. Compositions and methods for the antiseptic cleansing and biofilms treatment of mammalian tissue
CN110590927B (zh) * 2019-09-17 2022-06-14 济宁医学院 多疣壁虎抗氧化肽及其应用
CN111374317B (zh) * 2019-12-18 2022-08-30 苏州大学 一种天然抗菌肽Hc-CATH在食品防腐保鲜中的应用
CN111374169B (zh) * 2019-12-18 2022-08-30 苏州大学 一种天然抗菌肽As-CATH5在食品防腐保鲜中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830993A (en) * 1995-04-10 1998-11-03 Kansas State University Research Foundation Synthetic antimicrobial peptide
US20030022829A1 (en) * 2001-03-30 2003-01-30 Wendy Maury Novel antiviral activities primate theta defensins and mammalian cathelicidins
US7173007B1 (en) * 2003-04-02 2007-02-06 The Regents Of The University Of California Therapy for microbial infections
US7776823B2 (en) * 2003-10-21 2010-08-17 The Regents Of The University Of California Human cathelicidin antimicrobial peptides
CN1878789A (zh) 2003-10-21 2006-12-13 加利福尼亚大学董事会 人凯萨林菌素抗微生物肽
US7485619B2 (en) * 2005-01-31 2009-02-03 Yeon Sook KIM Antimicrobial agent
KR101326133B1 (ko) 2005-03-10 2013-11-06 삼성디스플레이 주식회사 평판 표시 장치 제조 시스템
US8202835B2 (en) * 2005-06-17 2012-06-19 Yitzchak Hillman Disease treatment via antimicrobial peptides or their inhibitors
AU2006330769A1 (en) * 2005-12-29 2007-07-05 Kansas State University Research Foundation Antimicrobial cathelicidin peptides
EP2200628A2 (en) * 2007-07-15 2010-06-30 Yitzchak Hillman Disease treatment via antimicrobial peptides or their inhibitors

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JPN6012016345; Ｃｕｒｒｅｎｔ　Ｐｒｏｔｅｉｎ　ａｎｄ　Ｐｅｐｔｉｄｅ　Ｓｃｉｅｎｃｅ Ｖｏｌ．６，　Ｎｏ．１, 200502, ｐｐ．２３-３４ *
JPN6012016346; ＳＡＮＧ，　Ｙ．　ｅｔ　ａｌ．: 'Ｄｉｆｉｎｉｔｉｏｎ：　Ｃａｎｉｓ　ｆａｍｉｌｉａｒｉｓ　ｃａｔｈｅｌｉｃｉｄｉｎ　ｍＲＮＡ，　ｃｏｍｐｌｅｔｅ　ｃｄｓ．' Ｄａｔａｂａｓｅ　ＤＤＢＪ／ＥＭＢＬ／ＧｅｎＢａｎｋ　［ｏｎｌｉｎｅ］，　Ａｃｃｅｓｓｉｎ　Ｎｏ．ＡＹ３９２０８９．１，　０１-ＭＡＹ-２００４　ｕｐｌｏａｄｅｄ , 20120322 *

Also Published As

Publication number Publication date
US7985832B2 (en) 2011-07-26
EP1966235A4 (en) 2010-01-06
WO2007076162A3 (en) 2008-09-12
AU2006330769A1 (en) 2007-07-05
EP1966235A2 (en) 2008-09-10
US20090221483A1 (en) 2009-09-03
CA2632782A1 (en) 2007-07-05
WO2007076162A2 (en) 2007-07-05
BRPI0621148A2 (pt) 2011-11-29
CN101351474A (zh) 2009-01-21

Similar Documents

Publication Publication Date Title
JP2009521932A (ja) 抗菌性カテリシジンペプチド
Zhang et al. Cloning and recombinant expression of a crustin-like gene from Chinese shrimp, Fenneropenaeus chinensis
Higgs et al. The synthetic form of a novel chicken β-defensin identified in silico is predominantly active against intestinal pathogens
Sang et al. Canine cathelicidin (K9CATH): gene cloning, expression, and biochemical activity of a novel pro-myeloid antimicrobial peptide
Sun et al. A novel cathelicidin from Bufo bufo gargarizans Cantor showed specific activity to its habitat bacteria
Wanniarachchi et al. Human defensin 5 disulfide array mutants: disulfide bond deletion attenuates antibacterial activity against Staphylococcus aureus
TW200950800A (en) Use of defensins against tuberculosis
Bruhn et al. Antimicrobial peptides and proteins of the horse-insights into a well-armed organism
JPH08508165A (ja) ウシ好中球由来の新規な抗微生物性ペプチド
JP2000513209A (ja) 抗微生物ペプチドと使用方法
KR101949210B1 (ko) 항염증 활성을 가진 인간 락토페린계 펩타이드
Li et al. A teleost complement factor Ba possesses antimicrobial activity and inhibits bacterial infection in fish
CN106659748A (zh) 不动杆菌属溶素
BRPI0609801A2 (pt) polipeptìdeo, polinucleotìdeo, construção de ácido nucleico, vetor de expressão recombinante, célula hospedeira recombinante, método para produção do polipeptìdeo, planta transgênica, parte de planta ou célula de planta, composição, método para matar ou inibir o crescimento de células microbianas, e, usos de um polipeptìdeo e de pelo menos um polipeptìdeo antimicrobiano
IL127319A (en) Formations of lactoprene and their uses
EP2396345B1 (en) Antimicrobial peptides based on cmap27
JP6130373B2 (ja) 病原性微生物、例えば、腸管出血性大腸菌（Ｅｓｃｈｅｒｉｃｈｉａｃｏｌｉ）（ＥＨＥＣ）に対して有効な新規の抗微生物ペプチドである、細菌によって形成されたミクロシンＳ（ｍｉｃｒｏｃｉｎＳ）
JP7454211B2 (ja) バクテリオファージ由来エンドライシン
EP1850861A1 (en) Systemic treatment of infections with defensins
CN102264383A (zh) 胞内细菌感染的处理
JP6921387B2 (ja) 抗微生物ポリペプチド
CN102036678A (zh) 针对脑膜炎的防卫素的用途
JP2005508151A (ja) メクラウナギカテリン関連抗菌ペプチドおよび遺伝子
KR20260034688A (ko) 소 유방염 원인 병원균에 대한 항균 펩타이드
Cao et al. In vitro and in vivo characterization of a new recombinant antimicrobial peptide, MP1102, against methicillin-resistant

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091221

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20091221

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101213

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120328

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120627

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120704

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120727

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120803

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20121022